Entering Germany’s Medical Cannabis Market

Choose the customer problem before the product pitch

Start with the organisation you want to serve and the decision it needs to make. A pharmaceutical manufacturer evaluating an ingredient has different questions from a distributor assessing a finished product. Define the proposed application, technical requirements and operational role before producing a broad sales presentation.

Potential opportunities can include supplying a defined material, improving the clarity of technical records or coordinating a complex handover. These are possibilities to test through buyer discussions, not evidence of guaranteed demand, a sales forecast or an assurance of regulatory acceptance.

Select a realistic operating model

Compare working with an established German partner with building your own local operation. In either case, identify who contracts, imports, stores, supplies and takes the relevant quality decisions. A partner relationship does not remove the need to establish which entity is responsible for each activity.

For imports of medicinal products from outside the EU or EEA, review the scope of § 72 AMG and the certificate provisions in § 72a AMG. Product classification and exceptions affect the route. Do not apply a finished-medicine model automatically to all active substances or extracts.

Prepare an evidence package a buyer can use

Build a concise package for the exact grade you intend to offer. It should identify the product, manufacturer, operating sites, specification, available batch data, packaging and proposed storage conditions. Clearly separate confirmed information from documents still being requested.

BfArM’s trader guidance requests evidence relevant to the proposed medical cannabis business and, for planned imports, the medical purpose and state-controlled cultivation of the source material. A foreign company’s commercial registration alone does not answer those product-specific questions.

Make quality and distribution responsibilities explicit

The EMA’s GMP overview explains that manufacturing and import responsibilities need to be assessed in the applicable EU framework. Check the exact site and operation covered by supporting evidence rather than relying on a generic “EU-ready” description.

For the proposed route, agree document handovers, shipment approval responsibilities, receipt checks and the handling of complaints or rejected material. Record who can resolve a quality question and who can authorise the next step. Include language and document-version arrangements where teams operate in different countries.

Plan for commercial and operational friction

Build a project plan that includes qualification work, document translations where needed, transport planning, packaging requirements and the possibility of delayed decisions. Model these as your own project assumptions and confirm them with the relevant participants; do not treat another company’s timeline as a regulatory commitment.

Discuss quantities, lead times, documentation costs, stock ownership and payment milestones alongside the technical review. Avoid exclusivity or large launch commitments before the operating model and evidence package are sufficiently clear for both parties.

Enter in stages and review the result

A staged approach makes the next decision easier: validate the buyer need, clarify the product route, qualify the partner, close documentation gaps and then assess whether a transaction can proceed. Agree what would count as a successful first engagement before scaling the relationship.

Dronivia’s services cover discussions around documentation support, market access and business relationships. A focused enquiry should describe the product, target organisation, origin, intended application and the support being sought, so the scope can be assessed without assuming a particular permission or outcome.